Medtronic's (MDT) Protect study confirms the long-term safety of drug-eluting coronary stents,...

|About: Medtronic plc (MDT)|By:, SA News Editor

Medtronic's (MDT) Protect study confirms the long-term safety of drug-eluting coronary stents, which slowly release a drug to block cell proliferation. The trial, the largest ever for such products, used Medtronic's Endeavor stent and J&J's (JNJ) Cypher to test for stent thrombosis, when a blood clot forms inside the stent. (PR)